 | | Vol. 15.31 – 17 August, 2023 |
| |
|
|
| A mouse inflammation array was used to detect the cytokine and chemokine profiles in the serum and placenta, and the infiltration characteristics of inflammatory cells in the placentas were evaluated by single-cell RNA sequencing.
[Ebiomedicine] |
|
|
|
 | | PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Scientists showed that Klf5 knockdown resulted in downregulation of core trophoblast stem cell-specific genes, consequently causing a rapid differentiation of trophoblast stem cells.
[Journal Of Molecular Cell Biology] |
|
|
|
| An in vivo paclitaxel-induced mice model was constructed to evaluate the reproductive toxicity and protective roles of hUC-MSCs in male fertility improvement.
[Biological Research] |
|
|
|
| To explore the role of HtrA4 in angiogenesis, HUVECs were co-cultured with wild-type BeWo cells, BeWo KO, and HtrA4-rescued BeWo KO cells.
[Biomedicine & Pharmacotherapy] |
|
|
|
| Human Wharton’s jelly MSCs were cultured in 3D using 100%, 75%, 50%, and 25% concentrations of fibrin-agarose biomaterials, and compared with control cells cultured using classical 2D systems.
[Frontiers In Bioengineering And Biotechnology] |
|
|
|
| This study included six adults with hematologic malignancies in remission. Romiplostim was administered subcutaneously within seven days after single-unit cord-blood transplantation, then once a week for 14 weeks or until platelet recovery.
[Annals Of Hematology] |
|
|
|
|
| The authors review the application of human umbilical cord-MSCs as a treatment for osteoarthritis. With the continuous development of routine clinical applications, more reliable intervention modalities for this treatment will be discovered for the time to come.
[Frontiers In Cell And Developmental Biology] |
|
|
|
|
| Printer Bio-Implant company joined the RegeneratOR’s Innovation Accelerator in 2023, located in the Regenerative Medicine Hub, a rapidly growing regenerative medicine ecosystem based in the Innovation Quarter, in Winston-Salem.
[Brinter Bio-Implant (EurekAlert!)] |
|
|
|
|
| October 5 – 7, 2023
Boston, Massachusetts, United States |
|
|
|
|
|
| | RareCyte – Seattle, Washington, United States |
|
|
|
| | Creative Biolabs – New York, New York, United States |
|
|
|
| | US FDA – Silver Spring, Maryland, United States |
|
|
|
| | IRB Barcelona – Barcelona, Spain |
|
|
|
| | Friedrich Miescher Institute for Biomedical Research – Basel, Switzerland |
|
|
|
|
Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell News
